PPMD Applauds FDA for Approval of AGAMREE® (Vamorolone) for Duchenne Patients Ages Two Years and Older

Posted on by

WASHINGTON, Oct. 26, 2023 /PRNewswire/ — Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), welcomed today’s decision by the Food and Drug Administration (FDA) to approve AGAMREE® (vamorolone) a dissociative…